BIOMAT Database Logo BIOMAT Database Logo

Separation of alpha-adrenergic and imidazoline/guanidinium receptive sites (IGRS) activity in a series of imidazoline analogues of cirazoline. 1995

L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Dípartimento di Scienze Farmaceutiche, Università di Modena, Italy.

To characterize the structure-activity relationship between alpha 1-adrenergic receptors and the family of imidazoline/guanidinium receptive sites (IGRS), we synthesized and characterized a series of analogues of cirazoline, an imidazoline with high affinity for alpha 1-adrenergic receptors and IGRS. Analysis of potency, affinity and efficacy of the synthesized molecules indicate different structure-activity relationships for IGRS and alpha-adrenergic receptors. Cirazoline exhibits a 25-fold higher affinity for IGRS (pKi 7.9) than for alpha 1-adrenergic receptors. Replacement of the cyclopropyl ring with an isopropoxy group resulted in a molecule that was 20-fold more selective for alpha 1-adrenergic receptors than for IGRS, i.e. a 500-fold increase in selectivity relative to cirazoline. The unsubstituted derivative 3 and the methyl and allyl substituted analogues 4 and 12 are of particular interest: compounds 3 and 4 recognize IGRS with high affinity (pKi 7.83 and 8.17) and high selectivity (398 and 123) with respect to the alpha 1-adrenergic receptor; compound 12 also recognizes IGRS with high affinity (pKi 8.08) and high selectivity (228 and 138) with respect to the alpha 2B and alpha 2C-adrenergic receptor subtypes. Thanks to their IGRS selectivity, these compounds represent novel and valuable pharmacological tools for the characterization and elucidation of the physiological role of these novel sites.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D054755 Imidazoline Receptors Receptors of CLONIDINE and other IMIDAZOLINES. Activity of the ligands was earlier attributed to ADRENERGIC ALPHA-2 RECEPTORS. Endogenous ligands include AGMATINE, imidazoleacetic acid ribotide, and harman. Imidazoline Receptor,Imidazoline-Guanidinium Receptor,Imidazoline-Guanidinium Receptors,Receptors, Imidazoline-Guanidinium,Imidazoline Guanidinium Receptor,Imidazoline Guanidinium Receptors,Receptor, Imidazoline,Receptor, Imidazoline-Guanidinium,Receptors, Imidazoline,Receptors, Imidazoline Guanidinium

Related Publications

L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Characterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liver.
April 1992, American journal of hypertension,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Relationship between alpha 2-adrenergic receptors and imidazoline/guanidinium receptive sites.
January 1998, Advances in pharmacology (San Diego, Calif.),
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Imidazoline-guanidinium receptive site (IGRS): mitochondrial distribution and regulation properties.
January 1992, Fundamental & clinical pharmacology,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
July 1994, Molecular pharmacology,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Visualization of multiple imidazoline/guanidinium-receptive sites.
July 1993, The Journal of biological chemistry,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites.
August 1992, European journal of pharmacology,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor.
July 1989, The Journal of biological chemistry,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
January 1997, Neurochemistry international,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
January 1991, European journal of pharmacology,
L Brasili, and M Pigini, and G Marucci, and W Quaglia, and L Malmusi, and S M Lanier, and B Lanier
Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.
April 1992, American journal of hypertension,
Copied contents to your clipboard!